Enzyme-activatable kidney-targeted dendrimer-drug conjugate for efficient childhood nephrotic syndrome therapy.

The incidence of childhood NS is as high as 4.71/100000, accounting for more than 30% of the total number of hospitalized children with an increasing trend annually 1 - 4 .

also in 63,971 other papers